Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data

Christiane Querfeld*, Julia J. Scarisbrick, Chalid Assaf, Youn H. Kim, Joan Guitart, Pietro Quaglino, Emmilia Hodak

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Background: Chlormethine gel was approved for treatment of mycosis fungoides, the most common cutaneous T-cell lymphoma, on the basis of results from study 201 and study 202. A post-hoc analysis of study 201 found interesting trends regarding improved efficacy of chlormethine gel vs ointment and noted a potential association between dermatitis and clinical response. Objective: To expand these results by performing a post-hoc analysis of study 202. Patients and Methods: Patients received chlormethine gel or ointment during study 201 (12 months) and higher-concentration chlormethine gel during study 202 (7-month extension). Response was assessed using Composite Assessment of Index Lesion Severity (CAILS). Associations between treatment frequency, response, and skin-related adverse events (AEs) were assessed using multivariate time-to-event analyses. Time-to-response and repeated measures analyses were compared between patients who only used chlormethine gel and those who switched from ointment to gel. Results: No associations were seen between treatment frequency and improved skin response (CAILS) or AE occurrence within the 201/202 study populations. However, an association was observed specifically between contact dermatitis and improved CAILS response at the next visit (p < 0.0001). Patients who used chlormethine gel during both studies had a significantly (p < 0.05) shorter time to response and higher overall response rates than patients who initiated treatment with ointment. Conclusions: This post-hoc analysis shows that patients who initiated treatment using chlormethine gel had faster and higher responses compared with patients who initially used chlormethine ointment for 12 months. The development of contact dermatitis may be a potential prognostic factor for response. Trial Registration Numbers and Dates of Registration: Study 201: NCT00168064, September 14, 2002; Study 202: NCT00535470, September 26, 2007.

Original languageEnglish (US)
Pages (from-to)561-570
Number of pages10
JournalAmerican Journal of Clinical Dermatology
Volume23
Issue number4
DOIs
StatePublished - Jul 2022

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data'. Together they form a unique fingerprint.

Cite this